Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pullar

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
British Journal of Clinical Pharmacology|June 1, 1988
The effect of allopurinol on the steady-state pharmacokinetics of indomethacinT Pullar, O Myall, J R Haigh, et al.
British Journal of Rheumatology|June 1, 1988
The effect of indomethacin on the psychomotor function of patients with rheumatic diseasesT Pullar, O Myall, J R Haigh, et al.
British Journal of Rheumatology|June 1, 1987
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazineT Pullar, A Zoma, H A Capell, et al.
Rheumatology (Oxford, England)|April 19, 2002
A case-control study examining the role of physical trauma in the onset of fibromyalgia syndromeA W Al-Allaf, K L Dunbar, N S Hallum, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidineC A Howes, T Pullar, I Sourindhrin, et al.
British Medical Journal (Clinical Research Ed.)|June 9, 1984
Value of test for antinuclear antibodies in rheumatic diseasesM M Steven, L G Teh, L S Teh, et al.
Rheumatology (Oxford, England)|August 31, 2006
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsK Chakravarty, H McDonald, T Pullar, et al.
Annals of the Rheumatic Diseases|May 1, 1996
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritisI B McInnes, D Porter, E A Murphy, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
British Journal of Clinical Pharmacology|June 1, 1988
The effect of allopurinol on the steady-state pharmacokinetics of indomethacinT Pullar, O Myall, J R Haigh, et al.
British Journal of Rheumatology|June 1, 1988
The effect of indomethacin on the psychomotor function of patients with rheumatic diseasesT Pullar, O Myall, J R Haigh, et al.
British Journal of Rheumatology|June 1, 1987
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazineT Pullar, A Zoma, H A Capell, et al.
Rheumatology (Oxford, England)|April 19, 2002
A case-control study examining the role of physical trauma in the onset of fibromyalgia syndromeA W Al-Allaf, K L Dunbar, N S Hallum, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidineC A Howes, T Pullar, I Sourindhrin, et al.
British Medical Journal (Clinical Research Ed.)|June 9, 1984
Value of test for antinuclear antibodies in rheumatic diseasesM M Steven, L G Teh, L S Teh, et al.
Rheumatology (Oxford, England)|August 31, 2006
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of DermatologistsK Chakravarty, H McDonald, T Pullar, et al.
Annals of the Rheumatic Diseases|May 1, 1996
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritisI B McInnes, D Porter, E A Murphy, et al.
Pageof 9